37
Views
28
CrossRef citations to date
0
Altmetric
Research Article

Increased risk of breast cancer following irradiation for Hodgkin‚s disease is not a result of ATM germline mutations

Pages 693-698 | Published online: 03 Jul 2009

  • ATHMA, P., RAPPAPORT, R. and SWIFT, M., 1996, Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genetics and Cytogenetics, 92, 130-134.
  • BARLOW, C., ECKHAUS, M. A., SCHAFFER, A. A. and WYNSHAWBORIS, A., 1999, Atm haplotype insufficiency results in increased sensitivity to sub-lethal doses of ionizing radiation in mice. Nature Genetics, 21, 359-360.
  • BHATIA, S., ROBISON, L. L., OBERLIN, O., GREENBERG, M., BUNIN, G., FOSSATI-BELLANI, F. and MEADOWS, A. T., 1996, Breast cancer and other second neoplasms after childhood Hodgkin's disease. New England Journal of Mediane, 334, 745-751.
  • BROEKS, A., DE KLEIN, A., FLOORE, A. N., MUIJTIENS, M., KLEIJER, W. J., JASPERS, N. G. and VAN T VEER, L. J., 1998, ATM germline mutations in classical ataxiatelangiectasia patients in the Dutch population. Human Mutation, 12, 330-337.
  • BROEKS, A., URBANUS, J. H. M., FLOORE, A. N., DAHLER, E. C., KLYN, J. G. M., RUTGERS, E. J. TH., DEVILEE, P., RUSSELL, H. S., VAN LEEUWEN, F. E. and VAN'T VEER, L. J., 2000, ATM heterozygous germline mutations contribute to breast cancer susceptibility. American Journal of Human Genetics, in press.
  • EASTON, D. F., 1994, Cancer risks in A-T heterozygotes. International Journal of Radiation Biology, 66, S177-S182.
  • FITZGERALD, M. G., BEAN, J. M., HEGDE, S. R., UNSAL, H., MACDONALD, D. J., HARKIN, D. P., FINKELSTEIN, D. M., ISSELBACHER, K. J. and HABER, D. A., 1997, Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nature Genetics, 15, 307-310.
  • GATTI, R. A., BODER, E., VINTERS, H. V., SPARKERS, R. S., NORMAN, A. and LANGE, K., 1991, Ataxia-telangiectasia: an interdisciplinary approach to pathogenesis. Medicine, 70, 99-117.
  • HANCOCK, S. L., TUCKER, M. A. and HOPPE, R. T., 1993, Breast cancer after treatment of Hodgkin's disease. International Journal of Radiation Biology, 85, 23-31.
  • LAVIN, M. F. and SHILOH, Y., 1996, Ataxia-telangiectasia: a multifaceted genetic disorder associated with defective signal transduction. Current Opinion of Immunology, 8, 459-464.
  • LAVIN, M. F. and SHILOH, Y., 1997, The genetic defect in ataxiatelangiectasia. Annual Review of Immunology, 15, 177-202.
  • NICHOLS, K. E., LEVITZ, S., SHANNON, K. E., WAHRER, D. C. R., BELL, D. W., CHANG, G., HEDGE, S., NEUBERG, D., SHAFMAN, T., TARBELL, N. J., MAUCH, P., ISHIOKA, C., HABER, D. A. and DILLAR, L., 1999, Heterozygous germline ATM mutations do not contribute to radiationassociated malignancies after Hodgkin's disease. Journal of Clinical Oncology, 17, 1259-1266.
  • PATCRSON, M. C., ANDERSON, A. K., SMITH, B. P. and SMITH, P. J., 1979, Enhanced radiosensitivity of cultured fibre-blasts from ataxia-telangiectasia heterozygotes manifested by defective colony-forming ability and reduced DNA repair replication after hypoxic gamma irradiation. Cancer Research, 39, 3725-3734.
  • PETCRSON, R. D., FUNKHOUSER, J. D., TUCK-MULLER, C. M. and GATTI, R. A., 1992, Cancer susceptibility in ataxiatelangiectasia. Leukemia, 6 (Suppl. 1), 8-13.
  • RAMSAY, J., BIRRELL, G. and LAVIN, M., 1996, Breast cancer and radiotherapy in ataxia-telangiectasia heterozygote. Lancet, 347, 1627.
  • RAMSAY, J., BIRRELL, G. and LAVIN, M., 1998, Testing for mutations of the ataxia-telangiectasia gene in radiosensitive breast cancer patients. Radiotherapy and Oncology, 47, 125-128.
  • SAVITSKY, K., BAR-SHIRA, A., GILAD, S., ROTMAN, G., ZIV, Y., VANAGAITC, L., TAGLE, D. A., SMITH, S., UZIEL, T., SFEZ, S., ASHKENAZI, M., PECKER, I., FRYDMAN, M., HARNIK, R., PATANIALI, S. R., SIMMONS, A., CLINES, G. A., SARTIEL, A., GATTI, R. A., CHESSA, L., SANAL, O., LAVIN, M. F., JASPERS, N. G. J., TAYLOR, M. R., ARLETT, C. F., MIKI, T., WEISSMAN, S. M., LOVETT, M., COLLINS, F. S. and SHILOH, Y., 1995, A single ataxia-telangiectasia gene with a product similar to PI-3 kinase. Science, 268, 1749-1753.
  • SEGDWICK, R. P. and BODER, E., 1991, Ataxia-telangiectasia. In Hereditary Neuropathies and Spinocerebeuar Atrophies, edited by J. M. B. Vianney de Jong (Amsterdam: Elsevier Science Publishers), pp. 347-423.
  • SHAFMAN, T., KHANNA, K. K., KEDAR, P., SPRING, K., KOZLOV, S., YEN, T., HOBSON, K., GATEI, M., ZHANG, N., WAITERS, D., EGERTON, M., SHILOH, Y., K HARBA NDA, S., KUFE, D. and LAVIN, M. F., 1997, Interaction between ATM protein and c-Abl in response to DNA damage. Nature, 387, 520-523.
  • SHILOH, Y., 1995, Ataxia-telangiectasia: closer to unravelling the mystery. European Journal of Human Genetics, 3, 116-138.
  • STOPPA-LYONNET, D., SOULIER, J., LAUGE, A., DASTOT, H., GARAND, R., SIGAUX, F. and STERN, M. H., 1998, Inactivation of the ATM gene in T-cell prolymphocytic leukemias. Blood, 91, 3920-3926.
  • TAYLOR, A. M., 1992, Ataxia-telangiectasia genes and predisposition to leukaemia, lymphoma and breast cancer. British Journal of Cancer, 66, 5-9.
  • TAYLOR, A. M. R., HERNANDEZ, D., MCCONVILLE, C. M., WOODS, C. G., STACEY, M., BIGGS, P., BYRD, P. J., ARLETT, C. F. and SCOTT, D., 1996, Malignant disease and variation in radiosensitivity in ataxia telangiectasia patients. In Genetic Predisposition to Cancer, edited by R. A. Eeles, B. A. J. Ponder and A. Horwich (London: Chapman & Hall), pp. 138-151.
  • TELATAR, M., TERAOKE, S., WANG, Z., CHUN, H.H., LIANG, T., CASTCLLI-BEL, S., UDAR, N., BORRESEN-DALE, A., CHESSA, L., BERNATOWSKA-MATUSZKIEWICZ, E., PORRAS, O., WATANABE, M., JUNKER, A., CONCANNON, P. and GATTI, R. A., 1998b, Ataxia-telangiectasia: identification and detection of founder effect mutations in the ATM-gene in ethnic populations. American Journal of Human Genetics, 62, 86-97.
  • TELATAR, M., WANG, Z., CASTCLLVI-BEL, S., SHEIKHAVANDI, S., REQUEIRO, J. R., PORRAS, O. and GATTI, R. A., 1998a, A model for ATM heterozygote identification in a large population: four founder-effect ATM mutations identify most of Costa Rican patients with ataxia telangiectasia. Molecular Genetics and Metabolism, 64, 36-43.
  • VAN LEEUWEN, F. E., KLOKMAN, W. J., HAGENBEEK, A., NOYON, R., VAN DER BELT-DUSEBOUT, A. W., VAN KERCKHOFF, E. H. M., VANHEERDE, P. and SOMERS, R., 1994, Second cancer risk following Hodgkin's disease: a 20-year follow-up study. Journal of Clinical Oncology, 12, 312-325.
  • VAN LEEUWEN, F. E., KLOKMAN, W. J., VAN T VEER, M., HAGENBEEK, A., VETTER, U. A. O., SCHAAPVELD, M., VAN HEERDE, P., BURGERS, J. M. V., SOMERS, R. and ALEMAN, B. M. P., 1999, Long-term risk of second cancers in adolescents and young adults treated for Hodgkin's disease. Journal of Clinical Oncology (in press).
  • WEEKS, D. E., PATERSON, M. C., LANGE, K., ANDRAIS, B., DAVIS, R. C., YODER, F. and GATTI, R. A., 1991, Assessment of chronic gamma radiosensitivity as an in vitro assay for heterozygote identification of ataxiatelangiectasia. Radiation Research, 128, 90-99.
  • WEST, C. M., ELYAN, S. A., BERRY, P., COWAN, R. and SCOTT, D., 1995, A comparison of the radiosensitivity of lymphocytes from normal donors, cancer patients, individuals with ataxia-telangiectasia (A-T) and A-T heterozygotes. International Journal of Radiation Biology, 68, 197-203.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.